ReForm Biologics Inc. Announces Appointments of Kevin Kavanaugh, CPA, to Chief Financial Officer and Robert Mahoney, PhD, to Chief Scientific Officer October 13, 2021 by Businesswire [#item_full_content] Related Spread the word
